| Entry |
|
| Name |
Aflibercept (genetical recombination) (JAN);
Aflibercept (USAN/INN);
Eylea (TN);
Zaltrap (TN)
|
| Product |
|
| Formula |
C4318H6788N1164O1304S32
|
| Exact mass |
96837.1694
|
| Mol weight |
96897.1957
|
| Sequence |
SDTGRPFVEM YSEIPEIIHM TEGRELVIPC RVTSPNITVT LKKFPLDTLI PDGKRIIWDS RKGFIISNAT YKEIGLLTCE ATVNGHLYKT NYLTHRQTNT IIDVVLSPSH GIELSVGEKL VLNCTARTEL NVGIDFNWEY PSSKHQHKKL VNRDLKTQSG SEMKKFLSTL TIDGVTRSDQ GLYTCAASSG LMTKKNSTFV RVHEKDKTHT CPPCPAPELL GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR DELTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS RWQQGNVFSC SVMHEALHNH YTQKSLSLSP G (Disulfide bridge: 30-79; 124-185; 246-306; 352-410, Dimer: 211; 214) |
| Type |
Peptide |
| Activity |
Inhibitor of aberrant angiogenesis-vascular leak and inflammation;
angiogenesis inhibitor for treatment of cancer
|
| Remark |
Therapeutic category: ATC code: |
| Comment |
fusion protein
VEGF-Trap
|
| Target |
|
| Pathway |
|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1319 Others
D09574 Aflibercept (genetical recombination) (JAN); Aflibercept (USAN/INN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01L OCULAR VASCULAR DISORDER AGENTS
S01LA Antineovascularisation agents
S01LA05 Aflibercept
D09574 Aflibercept (genetical recombination) (JAN); Aflibercept (USAN/INN)
Target-based classification of drugs [BR:br08310]
Cytokines
PDGF family
PGF [HSA:5228] [KO:K05448]
Aflibercept [ATC:S01LA05]
D09574 Aflibercept (genetical recombination) (JAN); Aflibercept (USAN/INN)
VEGFA [HSA:7422] [KO:K05448]
Aflibercept [ATC:S01LA05]
D09574 Aflibercept (genetical recombination) (JAN); Aflibercept (USAN/INN)
VEGFB [HSA:7423] [KO:K05449]
Aflibercept [ATC:S01LA05]
D09574 Aflibercept (genetical recombination) (JAN); Aflibercept (USAN/INN)
 |
| Other DBs |
|